The Association of Methotrexate, Sulfasalazine, and Hydroxychloroquine Use With Fracture in Postmenopausal Women With Rheumatoid Arthritis: Findings From the Women's Health Initiative

The Association of Methotrexate, Sulfasalazine, and Hydroxychloroquine Use With Fracture in Postmenopausal Women With Rheumatoid Arthritis: Findings From the Women's Health Initiative

ABSTRACT This study was conducted to evaluate the extent to which disease‐modifying antirheumatic medications (DMARDs) used as part of a triple therapy for the treatment of rheumatoid arthritis (RA) including methotrexate, sulfasalazine, and hydroxychloroquine are associated with fractures in postme...

Full description

Bibliographic Details
Main Authors: Laura Carbone, Sowmya Vasan, Rachel Elam, Sandeepkumar Gupta, Omar Tolaymat, Carolyn Crandall, Jean Wactawski‐Wende, Karen C Johnson
Format: Article
Language:English
Published: Wiley 2020-10-01
Series:JBMR Plus
Subjects:
COX PROPORTIONAL HAZARDS MODELING
DISEASE MODIFYING ANTIRHEUMATIC DRUGS
FRACTURE RISK ASSESSMENT
OSTEOPOROSIS
RHEUMATOID ARTHRITIS
Online Access:https://doi.org/10.1002/jbm4.10393

Internet

https://doi.org/10.1002/jbm4.10393

Similar Items